Regulation of mouse microglia activation and effector functions by bone marrow-derived mesenchymal stem cells

Stem Cells and Development

Volumn 23, Issue 21, 2014, Pages 2600-2612

  Hegyi, Beáta ^a   Környei, Zsuzsanna ^b   Ferenczi, Szilamér ^b   Fekete, Rebeka ^b   Kudlik, Gyöngyi ^a,c   Kovács, Krisztina J ^b   Madarász, Emília ^b   Uher, Ferenc ^c  

^a INSTITUTE OF MATERIALS AND ENVIRONMENTAL CHEMISTRY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c National Blood Service   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL ACTIVATION; CONTROLLED STUDY; INFLAMMATION; MICROGLIA; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; TISSUE REPAIR; ANIMAL; ANTIGEN PRESENTING CELL; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; COCULTURE; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; MACROPHAGE; MACROPHAGE ACTIVATION; MESENCHYMAL STROMA CELL; METABOLISM; NEWBORN; NUCLEAR REPROGRAMMING; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; ANTIGEN-PRESENTING CELLS; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; CELLULAR REPROGRAMMING; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; INTERLEUKIN-10; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MICROSCOPY, CONFOCAL; PHAGOCYTOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; T-LYMPHOCYTES;

EID: 84913612974     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0088     Document Type: Article

References (59)

1. Friedenstein A, R Chailakhjan and K Lalykina. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403.
2. da Silva Meirelles L, PC Chagastelles and NB Nardi. (2006). Mesenchymal stem cells reside in virtually all postnatal organs and tissues. J Cell Sci 119:2204-2213.
3. da Silva Meirelles L, AI Caplan and NB Nardi. (2008). In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26:2287-2299.
4. Beltrami AP, D Cesselli, N Bergamin, P Marcon, S Rigo, E Puppato, F DAurizio, R Verardo, S Piazza, et al. (2007). Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 110:3438-3446.
5. Uccelli A, L Moretta and V Pistoia. (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-736.
6. Dimarino AM, AI Caplan and TL Bonfield. (2013). Mesenchymal stem cells in tissue repair. Front Immunol 4:201.
7. Bernardo ME and WE Fibbe. (2013). Mesenchymal stromal cells: Sensors and switchers of inflammation. Cell Stem Cell 13:392-402.
8. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
9. Le Blanc K, L Tammik, B Sundberg, SE Haynesworth and O Ringden. (2003). Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57:11-20.
10. Corcione A, F Benvenuto, E Ferretti, D Giunti, V Cappiello, F Cazzanti, M Risso, F Gualandi, GL Mancardi, V Pistoia and A Uccelli. (2006). Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372.
11. Spaggiari GM, A Capobianco, S Becchetti, MC Mingari and L Moretta. (2006). Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107:1484-1490.
12. Maggini J, G Mirkin, I Bognanni, J Holmberg, IM Piazzo n, I Nepomnaschy, H Costa, C Canones, S Raiden, M Vermeulen and Jr. Geffner. (2010). Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 5:e9252.
13. Yanez R, A Oviedo, M Aldea, JA Bueren and ML Lamana. (2010). Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissuederived mesenchymal stromal cells. Exp Cell Res 316: 3109-3123.
14. Chen K, D Wang, W Du, Z Han, H Ren, Y Chi, S Yang, D Zhu, F Bayard and Z Han. (2010). Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE(2)-dependent mechanism. Clin Immunol 135:448-458.
15. Meisel R, A Zibert, M Laryea, U Gobel, W Daubener and D Dilloo. (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621.
16. Jones BJ, G Brooke, K Atkinson and SJ McTaggart. (2007). Immunosuppression by placental indoleamine 2,3-dioxygenase: A role for mesenchymal stem cells. Placenta 28:1174-1181.
17. Sato K, K Ozaki, I Oh, A Meguro, K Hatanaka, T Nagai, K Muroi and K Ozawa. (2007). Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109:228-234.
18. Ren G, L Zhang, X Zhao, G Xu, Y Zhang, AI Roberts, RC Zhao and Y Shi. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2:141-150.
19. Beyth S, Z Borovsky, D Mevorach, M Liebergall, Z Gazit, H Aslan, E Galun and J Rachmilewitz. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105: 2214-2219.
20. Sheng H, Y Wang, Y Jin, Q Zhang, Y Zhang, L Wang, B Shen, S Yin, W Liu, L Cui and N Li. (2008). A critical role of IFNg in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res 18: 846-857.
21. Xue Q, XY Luan, YZ Gu, HY Wu, GB Zhang, GH Yu, HT Zhu, M Wang, W Dong, YJ Geng and XG Zhang. (2010). The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity. Stem Cells Dev 19:27-38.
22. Shi D, L Liao, B Zhang, R Liu, X Dou, J Li, X Zhu, L Yu, D Chen and RC Zhao. (2011). Human adipose tissuederived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF-kB signaling. Exp Hematol 39:214-224.e1.
23. Gieseke F, J Bohringer, R Bussolari, M Dominici, R Handgretinger and I Mu ller. (2010). Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 116:3770-3779.
24. Krampera M, L Cosmi, R Angeli, A Pasini, F Liotta, A Andreini, V Santarlasci, B Mazzinghi, G Pizzolo, et al. (2006). Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386-398.
25. Ryan JM, F Barry, JM Murphy and BP Mahon. (2007). Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149:353-363.
26. Kim YJ, HJ Park, G Lee, OY Bang, YH Ahn, E Joe, HO Kim and PH Lee. (2009). Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 57:13-23.
27. Zhang QZ, WR Su, SH Shi, P Wilder-Smith, AP Xiang, A Wong, AL Nguyen, CW Kwon and AD Le. (2010). Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28:1856-1868.
28. Mosser DM and JP Edwards. (2008). Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
29. Nimmerjahn A, F Kirchhoff and F Helmchen. (2005). Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318.
30. Davalos D, J Grutzendler, G Yang, JV Kim, Y Zuo, S Jung, DR Littman, ML Dustin and WB Gan. (2005). ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752-758.
31. Zhou C, C Zhang, S Chi, Y Xu, J Teng, H Wang, Y Song and R Zhao. (2009). Effects of human marrow stromal cells on activation of microglial cells and production of inflammatory factors induced by lipopolysaccharide. Brain Res 1269:23-30.
32. Zhou C, C Zhang, R Zhao, S Chi and P Ge. (2013). Human marrow stromal cells reduce microglial activation to protect motor neurons in a transgenic mouse model of amyotrophic lateral sclerosis. J Neuroinflammation 10:52.
33. Kemp K, E Gray, E Mallam, N Scolding and A Wilkins. (2010). Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells. Stem Cell Rev 6:548-559.
34. Ooi YY, R Ramasamy, Z Rahmat, H Subramaiam, SW Tan, M Abdullah, DA Israf and S Vidyadaran. (2010). Bone marrow-derived mesenchymal stem cells modulate BV2 microglia responses to lipopolysaccharide. Int Immunopharmacol 10:1532-1540.
35. Giunti D, B Parodi, C Usai, L Vergani, S Casazza, S Bruzzone, G Mancardi and A Uccelli. (2012). Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells 30:2044-2053.
36. Rahmat Z, S Jose, R Ramasamy and S Vidyadaran. (2013). Reciprocal interactions of mouse bone marrow-derived mesenchymal stem cells and BV2 microglia after lipopolysaccharide stimulation. Stem Cell Res Ther 4:12.
37. Foraker JE, JY Oh, JH Ylostalo, RH Lee, J Watanabe and DJ Prockop. (2011). Cross-Talk between human mesenchymal stem/progenitor cells (MSCs) and rat hippocampal slices in LPS-stimulated cocultures: The MSCs are activated to secrete prostaglandin E2. J Neurochem 119:1052-1063.
38. Tseng FW, MJ Tsai, LY Yu, YS Fu, WC Huang and H Cheng. (2013). Comparative effects of bone marrow mesenchymal stem cells on lipopolysaccharide-induced microglial activation. Oxid Med Cell Longev 2013:234179.
39. Jung S, J Aliberti, P Graemmel, MJ Sunshine, GW Kreutzberg, A Sher and DR Littman. (2000). Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20:4106-4114.
40. Hegyi B, B Sagi, J Kovacs, J Kiss, VS Urban, G Meszaros, E Monostori and F Uher. (2010). Identical, similar or different? Learning about immunomodulatory function of mesenchymal stem cells isolated from various mouse tissues: Bone marrow, spleen, thymus and aorta wall. Int Immunol 22:551-559.
41. Saura J, JM Tusell and J Serratosa. (2003). High-yield isolation of murine microglia by mild trypsinization. Glia 44:183-189.
42. Sagi B, P Maraghechi, VS Urban, B Hegyi, A Szigeti, R Fajka-Boja, G Kudlik, K Nemet, E Monostori, E Gocza and F Uher. (2012). Positional identity of murine mesenchymal stem cells resident in different organs is determined in the postsegmentation mesoderm. Stem Cells Dev 21:814-828.
43. Nemeth K, A Leelahavanichkul, P Yuen, B Mayer, A Parmelee, K Doi, P Robey, K Leelahavanichkul, B Koller, et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42-49.
44. Gordon S. (2003). Alternative activation of macrophages. Nat Rev Immunol 3:23-35.
45. Valente AJ, MM Rozek, EA Sprague and CJ Schwartz. (1992). Mechanisms in intimal monocyte-macrophage recruitment. A special role for monocyte chemotactic protein-1. Circulation 86:III20-5.
46. Saijo K and CK Glass. (2011). Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11: 775-787.
47. Murray PJ and TA Wynn. (2011). Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11:723-737.
48. Ben-Mordechai T, R Holbova, N Landa-Rouben, T Harel-Adar, MS Feinberg, I Abd Elrahman, G Blum, FH Epstein, Z Silman, S Cohen and J Leor. (2013). Macrophage subpopulations are essential for infarct repair with and without stem cell therapy. J Am Coll Cardiol 62:1890-1901.
49. Bigildeev AE, OA Zhironkina, ON Lubkova and NJ Drize. (2013). Interleukin-1 beta is an irradiation-induced stromal growth factor. Cytokine 64:131-137.
50. Strowig T, J Henao-Mejia, E Elinav and R Flavell. (2012). Inflammasomes in health and disease. Nature 481:278-286.
51. Licandro G, H Ling Khor, O Beretta, J Lai, H Derks, F Laudisi, C Conforti-Andreoni, H Liang Qian, GG Teng, P Ricciardi-Castagnoli and A Mortellaro. (2013). The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells. Eur J Immunol 43:2126-2137.
52. Liu WH, JJ Liu, J Wu, LL Zhang, F Liu, L Yin, MM Zhang and B Yu. (2013). Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway. PLoS One 8:e55487.
53. Cheng P, Y Nefedova, CA Corzo and DI Gabrilovich. (2007). Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands. Blood 109:507-515.
54. Abumaree MH, MA Al Jumah, B Kalionis, D Jawdat, A Al Khaldi, FM Abomaray, AS Fatani, LW Chamley and BA Knawy. (2013). Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages. Stem Cell Rev 9:620-641.
55. Potian JA, H Aviv, NM Ponzio, JS Harrison and P Rameshwar. (2003). Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171:3426-3434.
56. Zhou Y, A Day, S Haykal, A Keating and TK Waddell. (2013). Mesenchymal stromal cells augment CD4 + and CD8 + T-cell proliferation through a CCL2 pathway. Cytotherapy 15:1195-1207.
57. Prevosto C, M Zancolli, P Canevali, MR Zocchi and A Poggi. (2007). Generation of CD4 + or CD8 + regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 92:881-888.
58. Maccario R, M Podesta, A Moretta, A Cometa, P Comoli, D Montagna, L Daudt, A Ibatici, G Piaggio, et al. (2005). Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4 + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90:516-525.
59. Casiraghi F, N Azzollini, P Cassis, B Imberti, M Morigi, D Cugini, RA Cavinato, M Todeschini, S Solini, et al. (2008). Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 181:3933-3946.